Literature DB >> 7273865

Organisation of the Danish adjuvant trials in breast cancer.

K W Andersen, H T Mouridsen, T Castberg, K Fischerman, J Andersen, K Hou-Jensen, H Brincker, H Johansen, E Henriksen, M Rørth, N Rossing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7273865

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN： 0907-8916


× No keyword cloud information.
  15 in total

1.  Immunoreactive opioid peptides in human breast cancer.

Authors:  L Scopsi; E Balslev; N Brünner; H S Poulsen; J Andersen; F Rank; L I Larsson
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Adjuvant chemotherapy with cyclophosphamide or CMF in premenopausal women with stage II breast cancer.

Authors:  H Brincker; H T Mouridsen; K W Andersen
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

3.  Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.

Authors:  C Rose; H T Mouridsen; S M Thorpe; J Andersen; M Blichert-Toft; K W Andersen
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

4.  Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.

Authors:  T Haerslev; G K Jacobsen; K Zedeler
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications.

Authors:  L Pedersen; S Holck; T Schiødt; K Zedeler; H T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

6.  Estrogen and progesterone receptor profile patterns in primary breast cancer.

Authors:  S M Thorpe; C Rose; B V Pedersen; B B Rasmussen
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

7.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Proliferating cell nuclear antigen in breast carcinomas. An immunohistochemical study with correlation to histopathological features and prognostic factors.

Authors:  T Haerslev; G K Jacobsen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Antiestrogen treatment of postmenopausal women with primary high risk breast cancer.

Authors:  C Rose; S M Thorpe; H T Mouridsen; J A Andersen; H Brincker; K W Andersen
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

10.  Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.

Authors:  C Kamby; B B Rasmussen; B Kristensen
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.